Helping To Revolutionize Cancer Treatment, Mikhail Blagosklonny

In the medical field today there is an amazing amount of research being done, delving deep into the inner workings of disease and the human body, what we can do to prevent disease as well as fight it. There are many in the medical health field that are working hard to research these new treatments and one of the most prolific is Mikhail Blagosklonny.

Mikhail is not only a professor of Oncology at Roswell Park Cancer Institute but he is also the Editor-in-Chief of Oncotarget, a twice weekly publication that is peer reviewed and focuses on bio-medical research. Most of the publications revolve around oncology and the treatments we are discovering for cancer. Read this article about Mikhail at inprogressmag.com.

One of the most powerful medicinal tools being used is Rapamycin, also known as Sirolimus or as its trade name, Rapamune. This wonder drug was discovered initially in 1972, isolated from a bacterium found on Easter Island. Initially it was used as an anti-fungal agent but when research into its potential was done, it was found to have extraordinary antiproliferative and immunosuppressive properties.

Mikhail Blagosklonny has worked diligently, researching into cancer and aging, began to research Rapamycin further to see what it could do for cancer treatment. It has been used very successfully in organ transplants, aiding the body by helping it to accept the new organ, reducing the risk of rejection.

The powers of Rapamycin in cancer treatment are showing extremely promising results, provided the medicine is taken in the right doses. Rapamycin can help bolster the body’s immune system, adding extra strength to the natural response of the body to the presence of tumors.

Read: http://www.phillypurge.com/2017/07/14/oncotarget-mikhail-blagosklonny-rapamycin-incredible-healing-properties/

One of Mikhail’s major research focal point has been the correlation between aging and cancer, why it is that the older our bodies become, the more susceptible we become to cancer and it appears to have a somewhat specific age threshold in which cancer become far more common.

The other major focus of Mikhail Blagosklonny is to find a treatment for cancer that is not only accessible to all, no matter their financial standing, but to also find a treatment method that is not an agonizing bombardment of chemicals on the body as it is today.

Throughout his career, Mikhail Blagosklonny has always put the focus on what will benefit people as a whole first, hoping that his endeavors will encourage other likeminded individuals to follow in his footsteps and help find a healthy way to cure the body of cancer. View his LinkedIn profile.

 

Leave a Comment